Skin & Recovery Peptides

Skin & Recovery Peptide Research

The Clavicular Stack's "GLOW" and "KLOW" designations reflect two distinct research approaches to skin optimization — collagen biology (GHK-CU) and neuromuscular ACh modulation (SNAP-8).

GHK-CU — GLOW Peptide

GHK-CU (glycyl-L-histidyl-L-lysine copper) is the most studied injectable/topical skin peptide in preclinical research. Key mechanisms:

• Collagen upregulation: Up to 70% increase in collagen Types I, III, VI in fibroblast studies
• Matrix remodeling: MMP activation removes damaged collagen; TIMP-1 upregulation prevents over-degradation of new collagen
• VEGF-driven angiogenesis: Increased skin capillary density — the physical basis of improved skin luminosity
• Cu-SOD activation: Antioxidant defense against UV/oxidative skin damage
• Hair follicle: VEGF upregulation in dermal papilla; follicle size normalization in alopecia models

Natural plasma GHK-CU concentrations decline from ~200 ng/mL (age 20) to ~80 ng/mL (age 60) — providing research rationale for exogenous administration.

SNAP-8 — KLOW Peptide

SNAP-8 (acetyl octapeptide-3) is a SNAP-25 N-terminal analog that competes for SNARE complex binding, partially inhibiting acetylcholine release at facial neuromuscular junctions. Research outcomes: reduced expression line depth from decreased facial muscle contraction force.

Paired with GHK-CU: GHK-CU addresses skin structure (collagen), SNAP-8 addresses muscle activity-driven skin aging (dynamic wrinkles).

BPC-157 — Tissue Repair

Beyond gastric protection, BPC-157 accelerates repair of tendons, ligaments, and muscle tissue through VEGF upregulation, enhanced collagen organization, and angiogenesis at injury sites.

TB-500 — Deep Recovery

Thymosin Beta-4 sequesters G-actin, enabling controlled cell migration in tissue repair. Anti-inflammatory via cytokine modulation. Often combined with BPC-157 for comprehensive connective tissue recovery.